Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

183 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Sepsis and multiple sclerosis: causative links and outcomes.
Miljković Đ, Stanisavljević S, Jensen IJ, Griffith TS, Badovinac VP. Miljković Đ, et al. Immunol Lett. 2021 Jul 25:S0165-2478(21)00117-6. doi: 10.1016/j.imlet.2021.07.008. Online ahead of print. Immunol Lett. 2021. PMID: 34320384
Modulation of Intestinal ILC3 for the Treatment of Type 1 Diabetes.
Stojanović I, Saksida T, Miljković Đ, Pejnović N. Stojanović I, et al. Among authors: miljkovic d. Front Immunol. 2021 Jun 3;12:653560. doi: 10.3389/fimmu.2021.653560. eCollection 2021. Front Immunol. 2021. PMID: 34149694 Free PMC article.
Paving the way towards an effective treatment for multiple sclerosis: advances in cell therapy.
Mansilla MJ, Presas-Rodríguez S, Teniente-Serra A, González-Larreategui I, Quirant-Sánchez B, Fondelli F, Djedovic N, Iwaszkiewicz-Grześ D, Chwojnicki K, Miljković Đ, Trzonkowski P, Ramo-Tello C, Martínez-Cáceres EM. Mansilla MJ, et al. Among authors: miljkovic d. Cell Mol Immunol. 2021 Jun;18(6):1353-1374. doi: 10.1038/s41423-020-00618-z. Epub 2021 May 6. Cell Mol Immunol. 2021. PMID: 33958746 Free PMC article. Review.
Complete Freund's adjuvant-free experimental autoimmune encephalomyelitis in Dark Agouti rats is a valuable tool for multiple sclerosis studies.
Lazarević M, Djedovic N, Stanisavljević S, Dimitrijević M, Stegnjaić G, Krishnamoorthy G, Mostarica Stojković M, Miljković Đ, Jevtić B. Lazarević M, et al. Among authors: miljkovic d. J Neuroimmunol. 2021 May 15;354:577547. doi: 10.1016/j.jneuroim.2021.577547. Epub 2021 Mar 16. J Neuroimmunol. 2021. PMID: 33765502
Benfotiamine reduces dendritic cell inflammatory potency.
Djedovic N, Božić I, Miljković Đ, Lavrnja I. Djedovic N, et al. Among authors: miljkovic d. Endocr Metab Immune Disord Drug Targets. 2020 Sep 5. doi: 10.2174/1871530320999200905114135. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2020. PMID: 32888286
International real-world study of DLL3 expression in patients with small cell lung cancer.
Rojo F, Corassa M, Mavroudis D, Öz AB, Biesma B, Brcic L, Pauwels P, Sailer V, Gosney J, Miljkovic D, Hader C, Wu M, Almarez T, Penault-Llorca F. Rojo F, et al. Among authors: miljkovic d. Lung Cancer. 2020 Sep;147:237-243. doi: 10.1016/j.lungcan.2020.07.026. Epub 2020 Jul 27. Lung Cancer. 2020. PMID: 32745892 Free article.
183 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page